NT-KO-003

NT-KO-003 · Neurotec Pharma

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NT-KO-003, covering 2014-03-18 to 2014-03-18. Get the full timeline:

Most recent: Clinical Trial Update: A Phase IIa Study of NT-KO-003 for Multiple Sclerosis [Phase 2]